Weight loss is a secondary effect
In our study, GLP-1 signaling score was negatively correlated with TMB in KIRP, THYM, MESO, READ, COAD, LIHC, OV, HNSC, THCA, BLCA, LUAD, KIRC, and STAD (Figure 9A)
Clinicians should factor in the possible risks of long-term treatment at higher doses as well as drug costs and availability when deciding whether to prescribe GLP-1 receptor agonists among patients with obesity
H tr cha lnh vt thng: Glutathione gip thc y qu trnh cha lnh vt thng bng cch tng cng sn xut collagen
Patients with prior medullary thyroid carcinoma or family history of MEN2 syndrome must avoid tirzepatide because of GLP-1 receptor activation on thyroid C-cells and theoretical malignancy risk
Access our compounded GHK-Cu here: References Pickart, L., & Margolina, A